AstraZeneca shares fall 3.13% in rough market session

10 articles · Updated · MarketWatch · May 1

The stock closed at £135.12 as the FTSE 100 slipped 0.14% to 10,363.93 in Friday trading.
AstraZeneca ended 14.11% below its 52-week high of £157.32, reached on 18 February.
Trading volume was 887,798 shares, well below the stock's 50-day average of 2.7 million, indicating relatively light activity during the decline.

Why did one drug's bad news sink AstraZeneca's stock despite strong profits and another drug's big win?

Are new US tariffs on medicines about to trigger a global pharmaceutical trade war and raise your drug costs?